| pubmed-article:12656744 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0010711 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0015133 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0020823 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0280803 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0034897 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0442967 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0733521 | lld:lifeskim |
| pubmed-article:12656744 | lifeskim:mentions | umls-concept:C0733688 | lld:lifeskim |
| pubmed-article:12656744 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:12656744 | pubmed:dateCreated | 2003-3-26 | lld:pubmed |
| pubmed-article:12656744 | pubmed:abstractText | Survival of patients with primary central nervous system lymphoma (PCNSL) has improved with methotrexate-based combination regimens and radiotherapy (RT). However, the prognosis of patients who fail or relapse after initial response is poor. Very little data is available on salvage treatment at recurrence. | lld:pubmed |
| pubmed-article:12656744 | pubmed:language | eng | lld:pubmed |
| pubmed-article:12656744 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:12656744 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:12656744 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:12656744 | pubmed:issn | 0902-4441 | lld:pubmed |
| pubmed-article:12656744 | pubmed:author | pubmed-author:MontserratEmi... | lld:pubmed |
| pubmed-article:12656744 | pubmed:author | pubmed-author:GrausFrancesc... | lld:pubmed |
| pubmed-article:12656744 | pubmed:author | pubmed-author:Arellano-Rodr... | lld:pubmed |
| pubmed-article:12656744 | pubmed:author | pubmed-author:López-Guiller... | lld:pubmed |
| pubmed-article:12656744 | pubmed:author | pubmed-author:BessellEric... | lld:pubmed |
| pubmed-article:12656744 | pubmed:author | pubmed-author:NomdedeuBenet... | lld:pubmed |
| pubmed-article:12656744 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:12656744 | pubmed:volume | 70 | lld:pubmed |
| pubmed-article:12656744 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:12656744 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:12656744 | pubmed:pagination | 219-24 | lld:pubmed |
| pubmed-article:12656744 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:meshHeading | pubmed-meshheading:12656744... | lld:pubmed |
| pubmed-article:12656744 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:12656744 | pubmed:articleTitle | Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. | lld:pubmed |
| pubmed-article:12656744 | pubmed:affiliation | Service of Hematology, Institut de Recerca Biomèdica August Pi i Sunyer, Hospital Clínic, Barcelona, Spain. | lld:pubmed |
| pubmed-article:12656744 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12656744 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12656744 | lld:pubmed |
